Your browser doesn't support javascript.
loading
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Hoadley, Katherine A; Yau, Christina; Hinoue, Toshinori; Wolf, Denise M; Lazar, Alexander J; Drill, Esther; Shen, Ronglai; Taylor, Alison M; Cherniack, Andrew D; Thorsson, Vésteinn; Akbani, Rehan; Bowlby, Reanne; Wong, Christopher K; Wiznerowicz, Maciej; Sanchez-Vega, Francisco; Robertson, A Gordon; Schneider, Barbara G; Lawrence, Michael S; Noushmehr, Houtan; Malta, Tathiane M; Stuart, Joshua M; Benz, Christopher C; Laird, Peter W.
Afiliação
  • Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: hoadley@med.unc.edu.
  • Yau C; Buck Institute for Research on Aging, Novato, CA 94945, USA; Department of Surgery, University of California, San Francisco, San Francisco, CA 94115, USA.
  • Hinoue T; Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Wolf DM; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94115, USA.
  • Lazar AJ; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Drill E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Taylor AM; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Cherniack AD; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Thorsson V; Institute for Systems Biology, Seattle, WA 98109, USA.
  • Akbani R; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Bowlby R; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
  • Wong CK; Department of Biomolecular Engineering, Center for Biomolecular Sciences and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
  • Wiznerowicz M; Poznan University of Medical Sciences, 61-701 Poznan, Poland; Greater Poland Cancer Centre, 61-866 Poznan, Poland; International Institute for Molecular Oncology, 60-203 Poznan, Poland.
  • Sanchez-Vega F; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Robertson AG; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
  • Schneider BG; Department of Medicine, Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Lawrence MS; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Massachusetts General Hospital Cancer Center and Department of Pathology, Harvard Medical School, Charlestown, MA 02129, USA.
  • Noushmehr H; Department of Neurosurgery, Henry Ford Health System, Detroit, MI 48202, USA; Department of Genetics, University of Sao Paulo, Ribeirao Preto, SP, 14049-900, Brazil.
  • Malta TM; Department of Neurosurgery, Henry Ford Health System, Detroit, MI 48202, USA; Department of Genetics, University of Sao Paulo, Ribeirao Preto, SP, 14049-900, Brazil.
  • Stuart JM; Department of Biomolecular Engineering, Center for Biomolecular Sciences and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
  • Benz CC; Buck Institute for Research on Aging, Novato, CA 94945, USA.
  • Laird PW; Van Andel Research Institute, Grand Rapids, MI 49503, USA. Electronic address: peter.laird@vai.org.
Cell ; 173(2): 291-304.e6, 2018 04 05.
Article em En | MEDLINE | ID: mdl-29625048
ABSTRACT
We conducted comprehensive integrative molecular analyses of the complete set of tumors in The Cancer Genome Atlas (TCGA), consisting of approximately 10,000 specimens and representing 33 types of cancer. We performed molecular clustering using data on chromosome-arm-level aneuploidy, DNA hypermethylation, mRNA, and miRNA expression levels and reverse-phase protein arrays, of which all, except for aneuploidy, revealed clustering primarily organized by histology, tissue type, or anatomic origin. The influence of cell type was evident in DNA-methylation-based clustering, even after excluding sites with known preexisting tissue-type-specific methylation. Integrative clustering further emphasized the dominant role of cell-of-origin patterns. Molecular similarities among histologically or anatomically related cancer types provide a basis for focused pan-cancer analyses, such as pan-gastrointestinal, pan-gynecological, pan-kidney, and pan-squamous cancers, and those related by stemness features, which in turn may inform strategies for future therapeutic development.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article